Proto Labs, Inc. PRLB
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 579.49M | 560.54M | 546.26M | 533.13M | 518.38M |
| Total Other Revenue | -- | 209.00K | 394.00K | 628.00K | 834.00K |
| Total Revenue | 579.49M | 560.54M | 546.26M | 533.13M | 518.38M |
| Cost of Revenue | 317.52M | 305.94M | 301.23M | 295.99M | 289.66M |
| Gross Profit | 261.97M | 254.60M | 245.03M | 237.14M | 228.72M |
| SG&A Expenses | 172.20M | 171.17M | 169.32M | 168.13M | 163.99M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 532.39M | 519.47M | 513.29M | 506.93M | 495.83M |
| Operating Income | 47.09M | 41.07M | 32.97M | 26.20M | 22.55M |
| Income Before Tax | 48.28M | 42.32M | 36.39M | 31.06M | 22.63M |
| Income Tax Expenses | 13.26M | 11.85M | 10.64M | 9.82M | 7.79M |
| Earnings from Continuing Operations | 35.02 | 30.48 | 25.75 | 21.24 | 14.84 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 35.02M | 30.48M | 25.75M | 21.24M | 14.84M |
| EBIT | 47.09M | 41.07M | 32.97M | 26.20M | 22.55M |
| EBITDA | 77.11M | 74.11M | 66.49M | 60.34M | 57.40M |
| EPS Basic | 1.46 | 1.28 | 1.08 | 0.89 | 0.62 |
| Normalized Basic EPS | 1.38 | 1.22 | 1.02 | 0.84 | 0.74 |
| EPS Diluted | 1.43 | 1.25 | 1.06 | 0.88 | 0.61 |
| Normalized Diluted EPS | 1.36 | 1.20 | 1.01 | 0.83 | 0.73 |
| Average Basic Shares Outstanding | 95.59M | 95.45M | 95.39M | 95.69M | 96.40M |
| Average Diluted Shares Outstanding | 97.31M | 97.06M | 96.75M | 96.90M | 97.20M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |